Evidence map›Paper›PMID 35774919›Full record

ArticleHealth psychology research2022

A Look at Commonly Utilized Serotonin Noradrenaline Reuptake Inhibitors (SNRIs) in Chronic Pain.

Christopher Robinson, Suhani Dalal, Ahish Chitneni, Anand Patil, Amnon A Berger, Syed Mahmood, Vwaire Orhurhu, Alan D Kaye, Jamal Hasoon

Open access · goldAbstract read
In one paragraph

Article in Health psychology research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. VortioxetineCurrent neuropharmacology · 2025
    Trial
  4. Review
  5. Review
  6. Management strategies for burning mouth syndrome: a comprehensive review.Journal of oral & facial pain and headache · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Observational
  13. Characteristics of pain symptoms in Parkinson's disease.Clinical parkinsonism & related disorders · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 2 countries.

Christopher RobinsonDepartment of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School.
Suhani DalalDepartment of Internal Medicine, Loma Linda University.
Ahish ChitneniDepartment of Physical Medicine & Rehabilitation, New York-Presbyterian (Columbia/Cornell).
Anand PatilTouro University California College of Medicine.
Amnon A BergerDepartment of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School.
Syed MahmoodDepartment of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School.
Vwaire OrhurhuDepartment of Anesthesiology and Perioperative Medicine, University of Pittsburgh Medical Center.
Alan D KayeDepartment of Anesthesia and Pain Management, Louisiana State University Health Sciences Center.
Jamal HasoonDepartment of Anesthesiology and Pain Medicine, University of Texas Medical Branch.ORCID 0000-0001-8227-1864
Hadassah Medical Center · ILBeth Israel Deaconess Medical Center · USLoma Linda University · USLouisiana State University Health Sciences Center New Orleans · USPresbyterian Hospital · USThe University of Texas Medical Branch at Galveston · USTouro University California · USUniversity of Pittsburgh Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose of Review: Chronic pain continues to be one of the leading healthcare cost burdens in the United States and is typically defined as ongoing pain, lasting longer than six months. Various treatment options exist for chronic pain, including physical therapy, medical management, pain psychology, and interventional therapies. Pain medications have been the mainstay of treatment for chronic pain conditions with an increasing use of membrane stabilizers and antidepressants to treat neuropathic pain conditions. Specifically, serotonin noradrenaline reuptake inhibitors (SNRIs) have been used to treat a range of pain conditions expanding from everyday use for depressive disorders. Recent Findings: SNRIs, including duloxetine, venlafaxine, and milnacipran, have demonstrated efficacy in reducing pain in musculoskeletal pain (chronic low back pain and osteoarthritis), fibromyalgia, and neuropathic pain conditions (peripheral diabetic neuropathy). Summary: The article describes the function, role, and use of SNRIs to treat chronic and neuropathic pain by altering the noradrenergic descending inhibitory pathways.

Indexed as

chronic painduloxetinemilnacipranneuropathic painSerotonin noradrenaline reuptake inhibitorsvenlafaxine

Identifiers

PMID35774919
PMCPMC9239373
OpenAlexW4281666576

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.